4.5 Article

Metabolic Reprogramming of the Immune Response in the Tumor Microenvironment

Journal

CANCER BIOLOGY & THERAPY
Volume 14, Issue 4, Pages 315-318

Publisher

LANDES BIOSCIENCE
DOI: 10.4161/cbt.23616

Keywords

metabolism; lymphocyte; immunotherapy; cancer; Warburg; mTOR; rapamycin

Categories

Funding

  1. NCI NIH HHS [R01 CA164062] Funding Source: Medline

Ask authors/readers for more resources

A Division of Cancer Biology, NCI-sponsored workshop Metabolic Reprogramming of the Immune Response in the Tumor Microenvironment was held October 2nd, 2012 in Bethesda, MD. The purpose of the workshop was to bring together cancer cell biologists and immunologists to explore the mechanistic relationships between the metabolic pathways used by cancer cells and antitumor immune cells and how this information could be used to improve cancer immunotherapy. At the conclusion of the workshop a general discussion focused on defining the major challenges and opportunities concerning the impact of metabolism on antitumor immunity and cancer immunotherapy as well as what tools, technologies, resources or community efforts are required to accelerate research in this area. Overall, future studies need to consider how cancer cell metabolic pathways differ from activated lymphocytes in order to define a therapeutic window for cancer therapy. Further, studies aimed at reprogramming the metabolic qualities of T cells with the goal of improving immunotherapy were considered a promising avenue.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available